Melting point 154～155℃

Boiling point 518.6±50.0 °C(Predicted)

Density 1.257±0.06 g/cm3(Predicted)

Flash point 267℃

Storage conditions room temp

characteristic:

Tranexamic acid is a derivative of aminotoluic acid. It is an anti-fibrinolytic hemostatic drug. The hemostatic mechanism is the same as aminocaproic acid and aminotoluic acid, but it has a stronger effect. The strength is 7-10 times that of aminocaproic acid. Twice as much as aminomethyl benzoic acid and similar in toxicity. The chemical structure of tranexamic acid is similar to that of lysine, and it can competitively inhibit the adsorption of plasminogen on fibrin, prevent its activation, protect the chemicalbook protein of fiber from being degraded and dissolved by plasmin, and finally achieve hemostatic effect. It is suitable for the treatment of various hemorrhages caused by acute or chronic, localized or systemic primary fibrinolytic hyperplasia, such as obstetric hemorrhage, renal hemorrhage, hemorrhage from prostatic hypertrophy, hemophilia, tuberculosis, gastric hemorrhage, liver, lung , Spleen and other internal organs bleeding after surgery; it can also be used for abnormal bleeding during surgery.